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Two rapid genotyping methods for hepatitis C 
virus (tiCV), the line probe assay (Inno-LiPA) and 
the subtype-specific core amplification system 
[Okamoto et al., (1992b) Journalof General Virol- 
ogy73:673-6791, were applied to 58 HCV isolates 
which were typed as type 1 (n = 37) and type 2 
(n = 21) by sequence analysis of the 5' untrans- 
lated region (5'UTR). The line probe assay tar- 
gets the 5'UTR and recognized 12 subtype la, 25 
subtype Ib, 18 subtype 2a, 2 subtype 2b and 1 
subtype 2d in accordance with sequence analy- 
sis of this region. Subtype-specific core amplifi- 
cation revealed 7 discrepancies among the 37 
type 1 isolates when compared to LiPA. A differ- 
ent subtype was observed in 3 isolates ( l a  ver- 
sus 1 b), 2 isolates remained untyped and 2 iso- 
lates showed a coinfection of subtype l a  and 1 b. 
The first 5 discrepancies were confirmed by se- 
quence analysis of the core region whereas the 
coinfection could not be confirmed. Of the 21 
type 2 isolates only one could be typed by sub- 
type-specific core amplification. HCV RNA was 
detected in all 21 cases after the general first 
round of polymerase chain reaction (PCR). Direct 
sequencing of the core region indicated se- 
quence variation as a source of failure. 
It is concluded that LiPA results are conclusive 
for typing of HCV. However, LiPA is hampered 
occasionally for subtyping by lack of subtype- 
specific sequence variation in 5'UTR. Subtyping 
results by subtype-specific core amplification 
were accurate. However, it seems that this assay 
is not suitable for the identification of genotype 2 
isolates that circulate in patients living in West- 
ern Europe. Q 1995Wiley-Liss, Inc. 
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INTRODUCTION 
Hepatitis C virus (HCV) is the major etiologic agent 
of post-transfusion non-A, non-B hepatitis [Choo et al., 
19891 and is classified as a distinct genus of the Flavi- 
viridae [Miller and Purcell, 19901. Several full-length 
[Choo et al., 1991; Kato et al., 1990; Okamoto et al., 
1991, 1992a; Takamizawa et al., 19911 and numerous 
partial [Bukh et al., 1992, 1993; Chan et al. 1992; 
Enomoto et al., 1990; Kleter et al., 1994; Mori et al., 
1992; Simmonds et al., 1993a; Stuyver et al., 1993bl 
HCV sequences have been reported and comparison of 
those sequences revealed considerable heterogeneity 
between isolates. Recently, a useful classification sys- 
tem, based on phylogenetic analyses, was proposed and 
has been accepted by the scientific community [Sim- 
monds et al., 19941. This system discriminates between 
types and subtypes. Genotypic variation seems to be 
maintained throughout the entire viral genome, al- 
though the level of heterogeneity differs considerably 
between the various regions of the genome. Nucleotide 
sequence variation ranges from approximately 10% in 
the 5' UTR [Chan et al., 19921 to nearly 50% in the E l  
[Bukh et al., 19931 and NS5 [Simmonds et al., 1993b1 
regions. Currently, there is evidence for the existence of 
a t  least 9 major types [Tokita et al., 1994133. 
Genotyping of HCV isolates is of particular interest 
for epidemiological studies [Dusheiko et al., 1994; 
McOmish et al., 19931. The success of antiviral treat- 
ment of chronic HCV infections appears to be related to 
the viral genotype [Hino et al., 1994; Kobayashi et al., 
1993; Tsubota et al., 1994; Yoshioka et al., 19921 and 
the level of viremia [Hagiwara et al., 1993; Kobayashi 
et al., 1993; Lau et al., 1993; Yoshioka et al., 19921. 
Genotyping can be undertaken by sequence analysis 
but this is tedious and time-consuming. Recently, sev- 
eral rapid methods for genotyping of HCV have been 
reported, including subtype-specific polymerase chain 
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by scoring the presence or absence of a purple precipi- 
tate at the probe lines. 
Genotyping by Subtype-Specific 
Core Amplification 
This rapid typing system was devleoped by Okamoto 
et al., [1992b] and is based on a universal first round 
PCR, followed by subtype-specific nested PCR. Four 
antisense primers in the second PCR yield subtype- 
specific amplification products of distinct lengths, al- 
lowing identification of subtypes l a ,  lb ,  2a and 2b by 
agarose gelelectrophoresis. In this study the originally 
described general sense primers 256 and 104 [Okamoto 
et al., 1992bl were replaced by, respectively, LD58c 
(5'-bio-GGTACTGCCTGATAGGGTGCTTGC; posi- 
tions -57 to -34) and LD58s (GCCTGATAGGG- 
TGCTTGC; positions -51 to -34). These new general 
sense primers are located in a completely conserved 
part of the 5'UTR whereas the original sense primers 
256 and 104 were not. The first round of PCR (40 cycles, 
1 rnin at 94"C, 2 rnin a t  48"C, 3 rnin at 72°C) was per- 
formed with LD58c and antisense primer 186c (ATI- 
TACCCCATGAGITCGGC; positions 410 to 391). One 
microliter of the first round PCR product was subjected 
to subtype-specific nested PCR (40 cycles, 1 min a t  
94"C, 1 min at 60"C, 1 min at 72°C) with universal sense 
primer LD58s and the four antisense primers 132 to 
135 as described [Okamoto et al., 1992b1, except for 
primer 133 which was slightly modified by degenera- 
tion (T and C) at position 273. The antisense primers 
132,133,134 and 135 are specific for HCV subtypes la ,  
lb ,  2a and 2b, respectively. In additon, antisense 
primer 296 (GGATAGGCTGACGTCTACCT; positions 
196 to 177), which is subtype la-specific, was also used 
for subtype-specific core amplification [Kinoshita et al., 
19931 and, together with subtype lb-specific primer 235 
(CGTGGAAGGCGACAAC; positions 175 to 190) used 
as a 32P radioactive labelled probe by Southern blot 
analysis. All PCR reactions were undertaken in a 
Biomed 60 PCR processor (Bittfurth, Germany). 
reaction (PCR) in the core region [Okamoto et al., 
1992b, 19931 or in the NS5B region [Chayama et al., 
19931, restriction fragment length polymorphism 
(RFLP) [McOmish et al., 1993; Murphy et al., 1994; 
Nakao et al., 19911, hybridization of PCR products with 
type-specific probes [Cha et al., 1992; Enomoto et al., 
19901 and reverse hybridization [Stuyver et al., 1993a; 
van Doorn et  al., 19941. 
In the present study, two of these rapid methods were 
applied to 58 type 1 and 2 isolates sequenced in the 
5'UTR region. HCV genotyping was carried out by re- 
verse hybridization with the line probe assay (LiPA), 
which is aimed at the 5'UTR region, and by the sub- 
type-specific core amplification system [Okamoto et al., 
1992bl. Discrepant results were analyzed. 
MATERIALS AND METHODS 
Patients 
Plasma samples were obtained by venepuncture and 
stored at -70°C. All 58 patients had elevated alanine 
aminotransferase (ALT) levels, histological changes 
compatible with HCV infection, antibodies to hepatitis 
C virus, no recent history of infection with hepatitis B 
virus, hepatitis A virus, cytomegalovirus or Epstein- 
Barr virus, and were between 26 and 74 years old. The 
patients live in the Netherlands or Belgium. 
HCV RNA PCR 
HCV RNA and cDNA were prepared as described 
previously [Kleter et al., 19931. For 5' UTR analysis, 
PCR (40 cycles, 1 rnin at 94"C, 2 min at 48"C, 3 rnin at 
72°C) was undertaken with antisense primer HCV19 
(GTGCACGGTCTACGAGACCT, positions - 1 to -20) 
and sense primer HCVl8 (GGCGACACTCCACCATA- 
GAT, positions -304 to -324) or sense primer HCV35 
positions -296 to -318; underlined sequences are not 
complementary to HCV). 
(TTGGCGGCCGCACTCCACCATGAATCACTCC-CC, 
Genotyping by LiPA Direct Sequencing of PCR Products 
Rapid genotyping of HCV isolates by analysis of the First round PCR Products from the 5' UTR were NJb- 
5'UTR region was carried out with the line probe assay Jetted to nested PCR with primers NCR3 (GGGGCG- 
(Inno-LiPA, Innogenetics, Gent, Belgium) [Stuyver et - GCCGCCACCATRRATCACTCCCCTGTGAGG, posi- 
1 9 ~ ~ 3 ~ 1 .  ~ ~ i ~ f l ~ ,  first round 5'UTR PCR products tions -288 to -314) and antisense primer LD58 (5'-bio- 
GGCCGGGGCGGCCGCCAAGCACCCTATCAGGCA- were subjected to nested PCR with primers HC3 
(TCTAGCCATGGCGTTAGTRYGAGTGT; positions G-TACCACAAGGC, positions -37 to -64). The first 
-264 to -238; R = A or G; Y = T or c) and HC4 (CAC- round PCR products from the core region had a biotin 
TCGCAAGCACCCTATCAGGCAGT; positions -29 to moiety at the 5' end of primer LD58c. Biotinylated PCR 
-54) in the presence of bio-ll-dUTP. After nested PCR 
the biotinylated DNA products were denatured by al- 
kaline treatment. Reverse hybridization of the DNA 
Products were captured onto StrePtavidin-Coated Para- 
magnetic particles (Dynabeads M-280, Dynal, Oslo, 
Norway) and processed as described previously [Hult- 
products to general and type-specific HCV probes man et lggl; K1eter et lgg4]. 
which are applied onto a cellulose membrane strip was 
carried out in the presence of tetramethyl ammonium Phylogenetic Analysis 
chloride. After stringent washing, alkaline phos- Molecular evolutionary distances between individual 
phatase and streptavidin conjungate were added. Fi- isolates were determined by the DNADIST program of 
nally, the HCV isolates were identified and classified the PHYLIP program version 3 . 5 ~  [Felsenstein, 19931. 
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TABLE I. Country of Birth of Patients Infected With HCV 
TvDe 1 and 2 
37 
Country of birth 
Belgium 
Germany 
Indonesia 
Italy 
Morocco 
Nigeria 
Spain 
Surinam 
The Netherlands 
Turkey 
HCV genotype 
1 2 
5 3 
1 
2 
1 3 
2 
1 
2 
9 
21 5 
3 
TABLE 11. Genotyping of 58 HCV Type 1 and 2 Isolates by 
LiPA (5‘ UTR) and Subtype-Specific Core Amplification 
LiPA Core 
132a 296b 
Type N Type N N 
l a  12 l a  8 7 
lb 1 1 
l a  + lb  2 2 
unty pea“ 1 2 
lb  25 l a  2 2 
lb 23 23 
2a 18 untyped 18 ndd 
2b 2 2b 1 nd 
untyped 1 nd 
2d 1 untyped 1 nd 
“Subtype-specific core amplification with antisense primers 132/133/ 
13411 35, 
bSubtype-specific core amplification with antisense primers 29611 33/ 
134/135. 
“Untyped: no reaction in the subtype-specific nested PCR. 
dnd not determined. 
Nucleotide Sequence Accession Number 
The nucleotide sequences have been deposited in the 
EMBL data library (accession numbers X58937- 
X58953, X78858-X78860 and X78862 for 5’UTR se- 
quences; 229444-229474 and for core sequences). 
RESULTS 
HCV isolates were obtained from a large population 
of patients participating in a study on treatment of 
chronic hepatitis C, organized by the Benelux Study 
Group [Brouwer et al., 19931. All patients lived in the 
Netherlands or Belgium and were born in different 
countries (Table I). After sequence analysis of the 
5’UTR region, 37 isolates were assigned as type 1 and 
21 as type 2. 
B’UTR Genotyping 
HCV genotyping as carried out by sequence analysis 
of the 5‘UTR [Kleter et al., 19941 and LiPA [van Doorn 
et al., 19941 resulted in identical subtyping for type 1 as 
well as type 2 isolates (Table 11). One type 2 isolate 
(NE92) has been provisionally classified as “28’ (acces- 
sion number X78862) because novel covariant muta- 
tions were observed at positions - 163 and - 122 [Kleter 
et al., 19941. Sequence analysis of the E l  and NS5B 
coding regions of this particular isolate confirmed the 
classification as a separate subtype within HCV geno- 
type 2 [Stuyver et al., 19941. 
Subtype-Specific Core Amplification 
The 58 type 1 and 2 isolates were analyzed subse- 
quently also by a modified version of the subtype-spe- 
cific core amplification method [Okamoto et al., 1992bl. 
In this study the general sense primers 256 and 104 
described originally were replaced by primers LD58c 
and LD58s, respectively. This modification was intro- 
duced to circumvent possible failure of amplification by 
the general primers due to primer target mismatches 
(Fig. 1, B207), a phenomenon which was also noticed by 
Okamoto et al. [19931. First round PCR products were 
obtained from all isolates and subsequent subtype-spe- 
cific amplification was completely dependent on the an- 
tisense primers employed in the nested PCR. The core 
typing results are summarized and compared with 
LiPA in Table 11. 
Type 1 isolates. In 2 of the 37 type 1 HCV isolates, 
coinfections of subtypes l a  and l b  were detected by 
subtype-specific core amplification, whereas these iso- 
lates were typed as subtype l a  by LiPA (Table 11). In 
order to confirm this finding, nested PCR products were 
analyzed by Southern blot hybridization with subtype 
la-  and lb-specific probes (Fig. 2). Probe 235, which is 
lb-specific, did not hybridize to the l b  fragment of 342 
bp. Probe 296, which is la-specific, hybridized to the 
255 pb (la) as well as the 342 bp (lb) PCR fragment. 
This result indicated the presence of l a  sequences also 
in the 342 bp (lb) PCR fragment (Fig. 2, lanes 12 and 
13) and therefore, the subtype l b  primer 133 had 
falsely amplified the subtype l a  sequence. Addition- 
ally, direct sequencing of the N-terminal core region 
indicated that these 2 isolates contain only subtype l a  
sequences. Direct sequencing of 17 of the 37 type 1 
isolates confirmed the subtype-specific core amplifica- 
tion results (Fig. 1). 
Two other isolates, NL29 and NL35, remained un- 
typed by subtype-specific core amplification (Table 11). 
Isolate NL35, typed as subtype l a  by 5’UTR analysis, 
could not be typed by subtype-specific core amplifica- 
tion (Fig. 2, lane 25). Moreover, Southern blot hybrid- 
izations of the first round PCR product with either 
subtype la-  or lb-specific probes (296 and 235, respec- 
tively) were also negative (Fig. 2, lane 24). Isolate 
NL29, typed as subtype l a  by 5’UTR analysis, was also 
identified as l a  by subtype-specific core amplification 
with primer 132 (Fig. 2, lane 23). However, nested PCR 
with primer 296 (la) instead of primer 132 did not yield 
a PCR fragment (Table 11). Southern blot hybridiza- 
tions of first and second round PCR products with sub- 
type la- and lb-specific probes were also negative (Fig. 
2, lanes 22 and 23). The isolates NL29 and NL35 were 
obtained from patients born in Morocco (Table 11). Phy- 
logenetic analysis of 310 nucleotides of the N-terminal 
core region revealed that these 2 isolates possibly be- 
long to an additional type 1 subtype (Table IIIA). Fur- 
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Type \ Primers 
and 
positions 
175 I r----ti321 204 
CGAGGTAGACGTCAGCCTATCCCCAAGGCT 
r 134  I 135  
302 ‘324 
GACCTTCCCGTCCCTCTTGGGCC 
25 1 2 70 
CTCTGTACGGAAACGAGGGT 
139 167 
CGCGCGACGAGAAAGACTTCCGAGCGGTC 
l a  
NL54 
NL9 
NL56 
NL57 
NL48 
NL43 
N L69 
l b  
HCV-J 
HCV-BK 
NL5 
NL6 
8207 
058 
084 
865 
875 
NL59 
probe 235 
I d  
NL35 
NL29 
2a 
HCJ-6 
2b 
HCJ-8 
NL42 
8201 
2c 
583 
2c pr imr’  
2d 
NE92 
2‘ 
NL49 
NL50 
NL33 
Be, Belgium; It, Italy; Ja, Japan; Mo, Morocco; Ne, The Netherlands; 
Ni, Nigeria, and Su, Surinam. HCV-J [Kato et al., 19901; HCV-BK 
[Takamizawa et al., 19911; HC-J6 and HC-J8 [Okamoto et al., 1991, 
1992al; S83 [Bukh et al., 19941;o ,genotype “2a” primer for European 
isolates as described by Silini et al. [1993]. 
135 (2b; Fig. 1). The obtained sequences showed also 
mismatches to  the HCV genotype “2a” primer for Euro- 
pean isolates as described by Silini et al, 119931. This 
primer appeared to  be specific for HCV genotype 2c 
(Fig. 1, S83). The genotype 2b isolate that was identi- 
fied by PCR contained only a single mismatch at the 
very 5‘ end of subtype-specific 2b primer 135 (Fig. 1, 
B201). 
Type 2 core sequences were subjected to phylogenetic 
analysis and molecular evolutionary distances were de- 
termined between the present and published HCV gen- 
otype 2a (n = 5), 2b (n = €9, 2c (S83) and 2d (NE92) 
sequences (Table IIIB). From this analysis it appeared 
that type 2 sequences are highly heterogeneous. The 3 
isolates [typed as genotype 2a by LiPA (Fig. 1, NL33, 
NL49 and NL50)I had greater molecular evolutionary 
distances to genotype 2a than the distances observed 
between type 2c and 2d (Table IIIB). The distances 
among the 3 isolates were also greater (range 0.0647- 
0.0765) than the maximum distance between confirmed 
genotype 2a sequences (Table IIIB, 0.0605). These re- 
Fig. 1. Comparison of type 1 and type 2 nucleotide sequences in the 
target region of the 2 universal sense (256 and 104) and the 4 subtype- 
specific antisense (132 llal, 133 Ilbl, 134 l2al and 135 L2bl) core prim- 
ers as described by Okamoto et al. [1992b]. Probes 296 and 235 are 
subtype la- and lb-specific, respectively. Dashes indicate identical 
nucleotides. The origin of the HCV isolates is given in parentheses: 
ther analysis of the E l  and NS5B regions confirmed 
classification into subtype Id (unpublished observa- 
tion). 
In 3 of the 37 type 1 isolates, different subtypes were 
detected when comparing 5‘UTR and Core typing. Two 
isolates, (NL69 and NL43) were typed as genotype l b  
by LiPA but as genotype l a  by subtype-specific core 
amplification (Fig. 2, lanes 16 and 18). In one isolate 
(NL59) the opposite was observed (Fig. 2, lane 20). Se- 
quences analysis of the N-terminal core region (nt 
1-310) confirmed the results of subtype-specific core 
amplification (Fig. 1). 
Type 2 isolates. All 21 samples of type 2 isolates as 
deduced from sequence analysis of 5’UTR were HCV 
RNA positive after the first round of PCR with general 
primers LD58c and 186c. After the subtype-specific 
nested PCR, only one isolate was typed as genotype 2b 
(Fig. 2, lane 4) whereas all other type 2 isolates re- 
mained untyped (Table 11). Five of the 20 untyped sam- 
ples were sequenced and 3 to 6 mismatches were found 
to the genotype 2 subtype-specific primers 134 (2a) or 
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TABLE 111. Molecular Evolutionary Distances (range and mean k S.D.) Between HCV 
Subtypes and Isolates in the Core Region (nt 1-310) 
A HCV twe 1 isolates 
Subtype/ 
isolate l a  l b  l c  NL29 
la  0.0065-0.0436 
l b  0.068Z0.1290 
l c  0.0572-0.0868 
NL29 0.059&0.0712 
NL35 0.0900-0.1097 
0.0259 i 0.0092 
0.0895 * 0.0128 
0.0738 & 0.0080 
0.0633 * 0.0037 
0.0947 ? 0.0035 
B 
0.0197-0.0641 
0.0369 i 0.0130 
0.0716-0.1242 0.0000-0.0230 
0.0941 2 0.0112 
0.0659 * 0.0109 
0.0853 i 0.0106 0.0990 k 0.0057 0.0524 
0.0177 -+ 0.0066 
0.0653 2 0.0057 
0.0489-0.0859 0.0593-0.0743 
0.0757-0.1009 0.0900-0.1053 
HCV tme 2 isolates 
" &  
Type 2a 2b 2c 2d 
2a 0.0262-0.0605 
0.0384 ? 0.0096 
0.1018 t 0.0135 
0.0805 * 0.0100 
0.0672 * 0.0107 0.0955 0.0056 0.0467 
0.0891 * 0.0093 0.1100 i 0.0124 0.0572 0.0533 
0.0821 * 0.0127 0.1020 k 0.0056 0.0616 0.0649 
0.0861 ? 0.0112 0.1068 -+ 0.0079 0.0717 0.0824 
2b 0.0719-0.1236 0.0065-0.0431 
2c 0.0711-0.0928 0.0858-0.1079 
2d 0.0600-0.0817 0.0860-0.1079 
0.0258 2 0.0094 
0.0937 2 0.0065 
NL33 0.0817-0.1037 0.1044-0.127 1 
NL49 0.0683-0.0975 0.0947-0.1093 
NL50 0.071&0.1008 0.097fL0.1166 
sults suggest that these 3 isolates belong to 3 additional 
HCV genotype 2 subtypes. This observation has been 
confirmed by sequence analysis of the E l  and NS5B 
regions (unpublished observations). Interestingly, 2 of 
the 3 new subtypes were detected in patients born in 
Surinam. In contrast to this heterogeneity, the core 
sequence of the two isolates typed as 2b by LiPA, were 
homologous to published 2b core sequences (Table 
IIIB). 
DISCUSSION 
The most reliable approach for genotypic classifica- 
tion of HCV isolates would be nucleotide sequencing of 
the entire RNA genome. Genotypic variation seems to 
be maintained throughout the viral genome [Chan et 
al., 19921 and therefore only part of the genome needs 
to be analyzed. However, for analysis of a large number 
of samples this is laborious and rapid HCV genotyping 
assays are therefore required. In this study subtyping 
of type 1 and type 2 HCV isolates was compared by two 
rapid assays, i.e., the LiPA and subtype-specific core 
amplification. 
5' UTR Genotyping by LiPA 
For detection of HCV viremia RT-PCR is generally 
aimed at the 5'UTR region. Therefore, LiPA offers a 
convenient method for genotyping of HCV isolates sup- 
plementary to HCV RNA detection in a routine diag- 
nostic setting. The 58 isolates in this study showed that 
all LiPA results were in accordance with the 5'UTR 
sequence analysis. However, in 7 (19%) of the 37 geno- 
type 1 isolates, subtyping results by LiPA were not 
similar to that obtained by subtype-specific core ampli- 
fication. In the case of 5 HCV isolates this observation 
may be explained by the minimal sequence difference 
between subtypes l a  and l b  at position -99. At this 
particular position subtype l a  contains an Adenosine 
whereas subtype l b  contains a Guanosine. This minor 
difference should be considered as lack of sufficient se- 
quence variation in the highly conserved 5' UTR be- 
tween subtypes l a  and lb, rather than by recombina- 
tion between these subtypes. On the other hand, 
nucleotide variations in the 5'UTR are analyzed thor- 
oughly by LiPA. Each genotype is recognized by 2 or 
more probes. By assessing hybridization to multiple 
probes, 2641% of the 5'UTR sequence is determined 
[Stuyver et al., 1993al. This contrasted the use of one 
subtype-specific primer for HCV genotyping in the sub- 
type-specific core amplification system. 
Subtype-Specific Core Amplification 
Two problems were encountered with subtype-spe- 
cific core amplification in this study population of resi- 
dents in Western Europe. First, although identification 
of type 1 isolates was clearly possible, 2 (5.5%) of the 37 
HCV type 1 isolates were diagnosed as a l a  and l b  
coinfection. Theoretically, this phenomenon could be 
explained by the presence of a small amount of subtype 
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Fig. 2. Identification of subtype-specific nested PCR products ob- 
tained with sense primer LD58c and antisense primers 132,133, 134 
and 135. Top: Ethidiumbromide staining of agarose gels. Middle: 
Southern blot hybridization with subtype la-specific probe 296. Bot- 
tom. Southern blot hybridization with subtype lb-specific probe 235. 
Typical results of subtype l a  (255 bp), l b  (342 bp), 2a (372 bp) and 2b 
(321 bp) are shown in lanes 1 to 4, respectively. Lanes 5 and 21 
l b  sequences that could have been detected by the 
highly sensitive nested PCR. However, direct-sequenc- 
ing and Southern blot analyses with subtype la-  and 
lb-specific probes revealed that these isolates only con- 
tained subtype l a  sequences. A more likely explanation 
therefore, seems to be imperfect annealing of primer 
133 to the genotype l a  genome, resulting in aspecific 
amplification [Andonov and Chaudhary, 19941. Non- 
specific amplification occurred only in HCV genotype 
l a  isolates (Figs. 1 and 2). The opposite phenomenon, 
i.e., nonspecific amplification of ’la‘ sequences in geno- 
type l b  isolates was not observed. 
Secondly, identification of type 2 isolates by subtype- 
specific core amplification was a major problem. Of the 
21 HCV genotype 2 isolates, only 1 isolate could be 
subtyped as genotype 2b although a positive result was 
obtained in all cases after the first round of PCR. The 
remaining 20 untyped isolates did not yield any nested 
PCR fragment, even after reducing the annealing tem- 
perature in the nested PCR to 55°C (data not shown). 
The antisense core primers are subtype-specific. There- 
fore, failure of the nested PCR may be explained by 
mismatches between the subtype-specific primers and 
their target sequences as is illustrated in Figure 1 (i.e., 
NL42: 3 mismatches to primer 135). 
contain marker DNA, i.e., pBR322 digested by Hinfl. Lanes 6 to 11 
show subtype l a  sequences. Lanes 12 and 13 show a coinfection of 
HCV subtypes l a  and lb.  Lane 14, negative PCR control. Lanes 15, 
17, 19, 22 and 24 show the first round PCR product of primerset 
LD58d186c and Lanes 16, 18,20,23 and 25 show nested PCR prod- 
ucts of isolate NL69 (la), NL43 (la), NL59 (lb), NL29 (Id) and NL35 
(Id), respectively. 
Recently, identical 5’UTR sequences were described 
for subtype 2a and 2c [Bukh et al., 19931. Therefore, it is 
possible that the 18 isolates, typed as 2a by LiPA, be- 
long to HCV genotype 2c. However, phylogenetic anal- 
ysis carried out on 3 of these 18 samples suggested that 
each of these isolates could be classified into yet an- 
other subtype. This observation suggests the existence 
of multiple subtypes among type 2 isolates in Western 
Europe and requires confirmation by sequence analysis 
of the E l  and NS5B regions. Theoretically, the subtype- 
specific “2a” primer as described by Silini et al. [1993] 
would not allow typing of the 3 type 2 isolates due to 
mismatches at essential positions (Fig. 1). These re- 
sults indicate that HCV type 2 isolates in our study 
population are considerably different from the pub- 
lished type 2 isolates from Japan [Okamoto et al., 
1991,1992bl. Technically, subtype-specific core amplifi- 
cation is a feasible assay for subtyping of HCV isolates. 
However, improvement of the subtype-specific core am- 
plification assay for typing of HCV isolates will be diffi- 
cult due to the extended variation among HCV sub- 
types. At present more than 29 HCV subtypes have 
been reported [Bukh et al., 1994; Stuyver et al., 1994; 
Tokita et al., 1994a,bl. 
In summary, it appeared that several HCV RNA iso- 
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lates remained untyped by subtype-specific core ampli- 
fication, indicating that this typing method is re- 
stricted to the patient population to be analyzed. 
Furthermore, rapid genotyping results obtained by ei- 
ther LiPA or subtype-specific core amplification were 
generally in accordance with sequence analysis at, re- 
spectively, the 5’UTR and core regions. However, the 
specificity of both rapid genotyping assays is occasion- 
ally hampered due to a lack or excess of sequence vari- 
ation in their respective target regions as is sequence 
analysis for HCV typing if restricted to one of these 
regions. 
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